BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21507822)

  • 1. A review of pharmacist contributions to diabetes care in the United States.
    Armor BL; Britton ML; Dennis VC; Letassy NA
    J Pharm Pract; 2010 Jun; 23(3):250-64. PubMed ID: 21507822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do researchers use pharmacists' communication as an outcome measure? A scoping review of pharmacist involvement in diabetes care.
    Babinec PM; Rock MJ; Lorenzetti DL; Johnson JA
    Int J Pharm Pract; 2010 Aug; 18(4):183-93. PubMed ID: 20636669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist roles in the management of patients with type 2 diabetes.
    Sisson E; Kuhn C
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S41-5. PubMed ID: 19801364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmaceutical care of patients with diabetes mellitus and its relationship to clinical pharmacy].
    Vlcek J; MalĂ˝ J; Dosedel M
    Vnitr Lek; 2009 Apr; 55(4):384-8. PubMed ID: 19449755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present.
    Benavides S; Rodriguez JC; Maniscalco-Feichtl M
    Ann Pharmacother; 2009 Jan; 43(1):85-97. PubMed ID: 19109213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services.
    Castelino RL; Bajorek BV; Chen TF
    Ann Pharmacother; 2009 Jun; 43(6):1096-106. PubMed ID: 19470856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical consultations in community pharmacies: utility of the Roter Interaction Analysis System to study pharmacist-patient communication.
    Cavaco A; Roter D
    Int J Pharm Pract; 2010 Jun; 18(3):141-8. PubMed ID: 20509347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' and patients' roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script?
    Worley MM; Schommer JC; Brown LM; Hadsall RS; Ranelli PL; Stratton TP; Uden DL
    Res Social Adm Pharm; 2007 Mar; 3(1):47-69. PubMed ID: 17350557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes.
    Sookaneknun P; Richards RM; Sanguansermsri J; Teerasut C
    Ann Pharmacother; 2004 Dec; 38(12):2023-8. PubMed ID: 15522983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review.
    Ponniah A; Anderson B; Shakib S; Doecke CJ; Angley M
    J Clin Pharm Ther; 2007 Aug; 32(4):343-52. PubMed ID: 17635336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacist model of perceived responsibility for drug therapy outcomes.
    Planas LG; Kimberlin CL; Segal R; Brushwood DB; Hepler CD; Schlenker BR
    Soc Sci Med; 2005 May; 60(10):2393-403. PubMed ID: 15748686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical care and health outcomes in community settings: a matched pair analysis of perceptions of hypertensive patients versus pharmacists.
    Franic D; Pathak DS; Mott D
    Pharm Pract Manag Q; 1999 Jul; 19(2):1-17. PubMed ID: 10558091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interventions to improve the management of diabetes mellitus in primary health care and outpatient community settings].
    Hansen LJ; Drivsholm TB
    Ugeskr Laeger; 2002 Jan; 164(5):607-9. PubMed ID: 11871208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing a pharmacist-patient relationship quality model among older persons with diabetes.
    Worley MM
    Res Social Adm Pharm; 2006 Mar; 2(1):1-21. PubMed ID: 17138498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agreement between pharmacists for problem identification: an initial quality measurement of cognitive services.
    LaFleur J; Larson BS; Gunning KM; Stoddard GJ; Madden C; Oderda L; Steinvoort C; Oderda GM
    Ann Pharmacother; 2009 Jul; 43(7):1173-80. PubMed ID: 19584393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review.
    Wubben DP; Vivian EM
    Pharmacotherapy; 2008 Apr; 28(4):421-36. PubMed ID: 18363526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists.
    Lindenmeyer A; Hearnshaw H; Vermeire E; Van Royen P; Wens J; Biot Y
    J Clin Pharm Ther; 2006 Oct; 31(5):409-19. PubMed ID: 16958818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes demo project puts pharmacists in DM driver's seat.
    Dis Manag Advis; 2003 Mar; 9(3):37-9, 33. PubMed ID: 12701448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.